BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25303497)

  • 21. Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: no impact on early mortality and intracranial hemorrhage.
    Chang MC; Chen TY; Tang JL; Lan YJ; Chao TY; Chiu CF; Ho HT
    Am J Hematol; 2007 Nov; 82(11):976-80. PubMed ID: 17636473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis.
    Thiébaut A; Thomas X; Belhabri A; Anglaret B; Archimbaud E
    Ann Hematol; 2000 Sep; 79(9):501-6. PubMed ID: 11043421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of hyperleukocytic adult acute myeloid leukaemia: a single-center retrospective study and review of literature.
    Marbello L; Ricci F; Nosari AM; Turrini M; Nador G; Nichelatti M; Tedeschi A; Vismara E; Morra E
    Leuk Res; 2008 Aug; 32(8):1221-7. PubMed ID: 18313749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction chemotherapy versus palliative treatment for acute myeloid leukemia in a consecutive cohort of elderly patients.
    Colovic M; Colovic N; Radojkovic M; Stanisavljevic D; Kraguljac N; Jankovic G; Tomin D; Suvajdzic N; Vidovic A; Atkinson HD
    Ann Hematol; 2012 Sep; 91(9):1363-70. PubMed ID: 22592651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxemia During Extreme Hyperleukocytosis: How Spurious?
    Van de Louw A; Desai RJ; Schneider CW; Claxton DF
    Respir Care; 2016 Jan; 61(1):8-14. PubMed ID: 26420901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic leukapheresis for hyperleukocytosis in acute myelocytic leukemia.
    Cuttner J; Holland JF; Norton L; Ambinder E; Button G; Meyer RJ
    Med Pediatr Oncol; 1983; 11(2):76-8. PubMed ID: 6572782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia-A systematic review and meta-analysis.
    Bewersdorf JP; Giri S; Tallman MS; Zeidan AM; Stahl M
    Transfusion; 2020 Oct; 60(10):2360-2369. PubMed ID: 32776542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis.
    Oberoi S; Lehrnbecher T; Phillips B; Hitzler J; Ethier MC; Beyene J; Sung L
    Leuk Res; 2014 Apr; 38(4):460-8. PubMed ID: 24472688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leucodepletion for hyperleucocytosis--first report on a novel technology featuring electronic interphase management.
    Schulz M; Bug G; Bialleck H; Serve H; Seifried E; Bönig H
    Vox Sang; 2013 Jul; 105(1):47-53. PubMed ID: 23384315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of allogeneic hematopoietic stem cell transplantation from matched siblings or unrelated donors during the first complete remission in patients with cytogenetically normal acute myeloid leukemia.
    Hsieh YY; Hong YC; Hsiao LT; Yu YB; Liu JH; Gau JP; Lin HN; Hsu YN; Chiou TJ; Chen PM; Tzeng CH; Liu CY
    Eur J Haematol; 2011 Mar; 86(3):237-45. PubMed ID: 21155895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic leukapheresis in patients with leukostasis secondary to acute myelogenous leukemia.
    De Santis GC; de Oliveira LC; Romano LG; Almeida Prado Bde P; Simoes BP; Rego EM; Covas DT; Falcao RP
    J Clin Apher; 2011; 26(4):181-5. PubMed ID: 21574176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of patients with acute myelogenous leukemia after second salvage therapy.
    Giles F; O'Brien S; Cortes J; Verstovsek S; Bueso-Ramos C; Shan J; Pierce S; Garcia-Manero G; Keating M; Kantarjian H
    Cancer; 2005 Aug; 104(3):547-54. PubMed ID: 15973664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukapheresis in childhood acute leukemias: single-center experience.
    Yilmaz D; Karapinar B; Karadaş N; Duyu M; Yazici P; Ay Y; Balkan C; Aydinok Y; Kavakli K
    Pediatr Hematol Oncol; 2014 May; 31(4):318-26. PubMed ID: 23988130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
    Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
    Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
    J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of leukopenia at the time of diagnosis in acute myeloid leukemia.
    Arellano M; Bernal-Mizrachi L; Pan L; Tighiouart M; Souza L; Guo X; McLemore M; Lima L; Sunay S; Heffner LT; Chen Z; Chen GZ; Langston A; Winton E; Khoury HJ
    Clin Lymphoma Myeloma Leuk; 2011 Oct; 11(5):427-32. PubMed ID: 21729688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics and clinical evolution of patients with acute myeloblastic leukemia in northeast Mexico: an eight-year experience at a university hospital.
    Jaime-Pérez JC; Brito-Ramirez AS; Pinzon-Uresti MA; Gutiérrez-Aguirre H; Cantú-Rodríguez OG; Herrera-Garza JL; Gomez-Almaguer D
    Acta Haematol; 2014; 132(2):144-51. PubMed ID: 24556725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic leukapheresis in hyperleukocytic leukaemias--the experience of a tertiary institution in Singapore.
    Tan D; Hwang W; Goh YT
    Ann Acad Med Singap; 2005 Apr; 34(3):229-34. PubMed ID: 15902342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center.
    Nan X; Qin Q; Gentille C; Ensor J; Leveque C; Pingali SR; Phan AT; Rice L; Iyer S
    Leuk Lymphoma; 2017 Sep; 58(9):1-11. PubMed ID: 28140714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment prognostic factors for overall survival in primary resistant acute myeloid leukemia.
    Colovic N; Tomin D; Vidovic A; Suvajdzic N; Jankovic G; Palibrk V; Djunic I; Djurasinovic V; Virijevic M
    Biomed Pharmacother; 2012 Dec; 66(8):578-82. PubMed ID: 23085253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.